UPDATE : Monday, September 7, 2020
상단여백
Anticoagulant drugs will add SJS Warning
The approval conditions of nine medicines that include rivaroxaban, such as...
by Lee Hye-seon  |  2017-09-13 15:55
라인
Hanall Biopharma made $81-million technology export to China
Hanall Biopharma said Tuesday it has licensed out two new bio drugs under d...
by Lee Hye-seon  |  2017-09-13 13:23
라인
Court takes side with druggists despite leakage of personal info
About 2,000 doctors and patients filed a damage suit of 5.4 billion won ($4...
by Lee Hye-seon  |  2017-09-12 15:43
라인
FIP head calls for revitalizing generic substitution
International Pharmaceutical Federation (FIP) has come forward to emphasize...
by Lee Hye-seon  |  2017-09-12 14:34
라인
MFDS chief come under fire for impropriety
Minister of Food and Drug Safety (MFDS) Ryu Young-jin took an inappropriate...
by Lee Hye-seon  |  2017-09-11 17:52
라인
Yonsei University takes lead in social medicine
New medical technologies, including genomic editing called CRISPR, reproduc...
by Lee Hye-seon  |  2017-09-04 17:22
라인
‘Hospital pharmacists need enhanced role’
Hospital pharmacists’ role to guarantee patient safety should be enhanced w...
by Lee Hye-seon  |  2017-09-01 14:26
라인
Leukemia drug Imbruvica shows hepatitis B reactivation
The Ministry of Food and Drug Safety (MFDS) will change approval conditions...
by Lee Hye-seon  |  2017-08-31 16:08
라인
Abbvie gets approval for phase 3 clinical trials to treat Crohn’s disease
Abbvie’s new drug Risankizumab, being developed to treat the Crohn’s diseas...
by Lee Hye-seon  |  2017-08-31 15:49
라인
Annual output of hypertension, hyperlipidemia drugs surpasses ￦1 tri. respectively
The manufacturing output of the antiarteriosclerotic agent, antibiotic, ant...
by Lee Hye-seon  |  2017-08-30 16:08
라인
Hanmi plans to release Tefovir early October
Hanmi Pharmaceutical said Tuesday it will release Tefovir Tab (compound: te...
by Lee Hye-seon  |  2017-08-29 17:12
라인
Legal disputes between PMG Pharm, generics firms intensify over Layla
Legal disputes between PMG Pharm Korea and generics companies including Mot...
by Lee Hye-seon  |  2017-08-29 16:25
라인
16 local pharmaceutical firms obtain preferential rights to sell Viread
Sixteen Korean pharmaceutical companies obtained preferential rights from t...
by Lee Hye-seon  |  2017-08-28 14:22
라인
Warning on esomeprazole compound against rhabdomyolysis
Regulators have added rhabdomyolysis – melting of cross-striated musc...
by Lee Hye-seon  |  2017-08-25 17:17
라인
Regulators tell 68 firms to revalidate inflammation therapies’ efficacy
Sixty-eight inflammatory diseases therapies that failed to prove effectiven...
by Lee Hye-seon  |  2017-08-24 18:13
라인
‘Hospital druggists are guardians protecting patients from medication error’
So many hospitals are offering multidisciplinary treatments that it has lon...
by Lee Hye-seon  |  2017-08-22 15:09
라인
27 ‘innovative’ drugmakers spend ￦588 billion on R&D
Twenty-seven “innovative” drugmakers invested 588.2 billion won ($517.7 mil...
by Lee Hye-seon  |  2017-08-17 16:31
라인
Ministry to focus on stable supply of essential drugs
The Ministry of Food and Drug Safety (MFDS) will create a basis for the sta...
by Lee Hye-seon  |  2017-08-17 13:56
라인
Patent expiry of Lyrica, Tamiflu heats up generic market
The patents of painkiller Lyrica and influenza therapy Tamiflu with annual ...
by Lee Hye-seon  |  2017-08-16 16:36
라인
Green Cross steps up localization of tuberculosis vaccine
Green Cross has won the approval of phase 1 clinical trial plan of BCG vacc...
by Lee Hye-seon  |  2017-08-14 17:13
-이전1112131415-
176 civic groups furious over government-doctors deal176 civic groups furious over government-doctors deal
여백
Most viewed
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top